Skip to Main Content

ParkScreen is a multimodal Parkinson's disease screening decision aid that fuses three task-matched user recordings — sustained vowels /i/o/u/ for phonation (jitter, shimmer, HNR, F0 via Parselmouth), rapid /pa-ta-ka/ for articulation (DDK rate + regularity via intensity-envelope peak picking, no ASR), and an 8–12s smile-vs-neutral video for facial hypomimia (OpenFace AUs, Islam 2023 protocol). Two layers: an offline scientific spine trains per-channel LogReg classifiers on NeuroVoz with subject-level LOSO, and a real-time product layer scores user uploads with those fitted models, fuses via AUC-excess-weighted late fusion, and passes structured context into Claude Opus 4.7 to generate a hedged, disclaimer-bounded clinical-style report. Cross-channel disagreements are surfaced as "flagged for clinical review," never silently reconciled. On NeuroVoz (49 PD × 46 age-matched HC, N=95), phonation-only AUC is 0.567, DDK-only 0.740, and fused phonation+DDK 0.758 [0.662, 0.859] — fusion beats the strongest single channel. The separately-trained facial classifier hits in-distribution AUROC 0.812 on UFNet vs the paper's 0.830 SVM ensemble, and 0.708 on YouTubePD's external subset. Sensitivity analyses show DDK carries the load, dropping /a/e/ and steady-window-cropping vowels is what makes phonation non-degenerate, and a ~5-year PD-vs-HC age gap (p=0.013) accounts for a quantifiable slice of the AUC. This matters because PD is a motor-speech disorder — jitter/shimmer/HNR and DDK are direct mechanistic evidence, not proxy signals — and score-level fusion of small interpretable models is the honest choice at N=95, where deep fusion would overfit and obscure which channel is doing the work. The Claude layer solves the last mile: raw probabilities aren't clinically actionable, but a structured narrative with unit-labeled features, hedged language, mandatory disclaimers (screening-only + ON-medication caveat), and explicit disagreement flags is. Positioned as a decision aid, never a diagnosis.

Team

chiweihu

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview